- Home
- DDL vs IRWD Comparison
DDL vs IRWD Comparison
Compare DDL & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- IRWD
- Stock Information
- Founded
- DDL 2014
- IRWD 1998
- Country
- DDL China
- IRWD United States
- Employees
- DDL N/A
- IRWD N/A
- Industry
- DDL Catalog/Specialty Distribution
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- IRWD Health Care
- Exchange
- DDL Nasdaq
- IRWD Nasdaq
- Market Cap
- DDL 745.0M
- IRWD 716.9M
- IPO Year
- DDL 2021
- IRWD 2010
- Fundamental
- Price
- DDL $4.08
- IRWD $3.34
- Analyst Decision
- DDL Sell
- IRWD Buy
- Analyst Count
- DDL 1
- IRWD 4
- Target Price
- DDL $1.15
- IRWD $12.00
- AVG Volume (30 Days)
- DDL 1.7M
- IRWD 1.5M
- Earning Date
- DDL 11-06-2024
- IRWD 11-07-2024
- Dividend Yield
- DDL N/A
- IRWD N/A
- EPS Growth
- DDL N/A
- IRWD N/A
- EPS
- DDL 0.13
- IRWD N/A
- Revenue
- DDL $3,158,412,712.00
- IRWD $378,418,000.00
- Revenue This Year
- DDL $11.04
- IRWD N/A
- Revenue Next Year
- DDL $10.96
- IRWD N/A
- P/E Ratio
- DDL $33.01
- IRWD N/A
- Revenue Growth
- DDL 4.61
- IRWD N/A
- 52 Week Low
- DDL $1.07
- IRWD $3.31
- 52 Week High
- DDL $4.60
- IRWD $15.70
- Technical
- Relative Strength Index (RSI)
- DDL 55.72
- IRWD 33.13
- Support Level
- DDL $3.85
- IRWD $3.96
- Resistance Level
- DDL $4.38
- IRWD $5.07
- Average True Range (ATR)
- DDL 0.33
- IRWD 0.33
- MACD
- DDL -0.02
- IRWD -0.12
- Stochastic Oscillator
- DDL 58.19
- IRWD 1.70
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.